GSA Capital Partners’s Tenet Healthcare THC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-1,800
| Closed | -$340K | – | 2167 |
|
|
2026
Q1 | $340K | Sell |
1,800
-2,802
| -61% | -$590K | 0.02% | 1176 |
|
|
2025
Q4 | $915K | Buy |
4,602
+2,711
| +143% | +$548K | 0.08% | 417 |
|
|
2025
Q3 | $384K | Sell |
1,891
-2,202
| -54% | -$391K | 0.03% | 1040 |
|
|
2025
Q2 | $720K | Sell |
4,093
-2,850
| -41% | -$429K | 0.05% | 672 |
|
|
2025
Q1 | $934K | Buy |
6,943
+2,129
| +44% | +$280K | 0.08% | 386 |
|
|
2024
Q4 | $608K | Buy |
4,814
+761
| +19% | +$113K | 0.05% | 747 |
|
|
2024
Q3 | $674K | Buy |
+4,053
| New | +$613K | 0.05% | 718 |
|
|
2024
Q2 | – | Sell |
-5,347
| Closed | -$562K | – | 2023 |
|
|
2024
Q1 | $562K | Buy |
5,347
+1,874
| +54% | +$168K | 0.04% | 808 |
|
|
2023
Q4 | $262K | Sell |
3,473
-1,107
| -24% | -$70.2K | 0.02% | 1186 |
|
|
2023
Q3 | $302K | Sell |
4,580
-5,854
| -56% | -$438K | 0.03% | 1073 |
|
|
2023
Q2 | $849K | Buy |
+10,434
| New | +$743K | 0.08% | 410 |
|
|
2022
Q4 | – | Sell |
-7,361
| Closed | -$380K | – | 1882 |
|
|
2022
Q3 | $380K | Buy |
+7,361
| New | +$437K | 0.05% | 776 |
|
|
2021
Q1 | – | Sell |
-7,211
| Closed | -$288K | – | 1491 |
|
|
2020
Q4 | $288K | Buy |
+7,211
| New | +$233K | 0.05% | 759 |
|
|
2020
Q2 | – | Sell |
-16,656
| Closed | -$240K | – | 1095 |
|
|
2020
Q1 | $240K | Buy |
+16,656
| New | +$478K | 0.06% | 638 |
|
|
2019
Q4 | – | Sell |
-19,931
| Closed | -$441K | – | 1727 |
|
|
2019
Q3 | $441K | Buy |
+19,931
| New | +$425K | 0.06% | 627 |
|
|
2019
Q1 | – | Sell |
-85,951
| Closed | -$1.47M | – | 1694 |
|
|
2018
Q4 | $1.47M | Buy |
85,951
+77,572
| +926% | +$1.88M | 0.17% | 106 |
|
|
2018
Q3 | $238K | Buy |
+8,379
| New | +$277K | 0.01% | 1424 |
|
|
2017
Q2 | – | Sell |
-13,965
| Closed | -$247K | – | 1951 |
|
|
2017
Q1 | $247K | Buy |
13,965
+87
| +0.6% | +$1.61K | 0.01% | 1484 |
|
|
2016
Q4 | $206K | Buy |
13,878
+2,856
| +26% | +$51.2K | 0.01% | 1584 |
|
|
2016
Q3 | $250K | Sell |
11,022
-3,065
| -22% | -$79.8K | 0.01% | 1483 |
|
|
2016
Q2 | $389K | Buy |
+14,087
| New | +$416K | 0.02% | 1226 |
|
|
2016
Q1 | – | Sell |
-28,942
| Closed | -$877K | – | 1910 |
|
|
2015
Q4 | $877K | Sell |
28,942
-115,245
| -80% | -$3.78M | 0.04% | 795 |
|
|
2015
Q3 | $5.32M | Buy |
144,187
+107,197
| +290% | +$5.54M | 0.26% | 36 |
|
|
2015
Q2 | $2.14M | Buy |
36,990
+9,772
| +36% | +$499K | 0.08% | 327 |
|
|
2015
Q1 | $1.35M | Buy |
+27,218
| New | +$1.27M | 0.05% | 639 |
|
|
2014
Q3 | – | Sell |
-10,087
| Closed | -$473K | – | 1929 |
|
|
2014
Q2 | $473K | Buy |
+10,087
| New | +$456K | 0.02% | 1180 |
|
|
2014
Q1 | – | Sell |
-14,251
| Closed | -$600K | – | 1797 |
|
|
2013
Q4 | $600K | Sell |
14,251
-5,168
| -27% | -$225K | 0.05% | 707 |
|
|
2013
Q3 | $800K | Sell |
19,419
-12,903
| -40% | -$540K | 0.06% | 481 |
|
|
2013
Q2 | $1.49M | Buy |
+32,322
| New | +$1.45M | 0.18% | 113 |
|
Other funds holding THC
GCM
GSA Capital Partners's THC Position: Q2 2026 in Review
GSA Capital Partners sold out of Tenet Healthcare (THC) in Q2 2026, closing a stake of 1,800 shares — an estimated $340K sold.
GSA Capital Partners first reported a position in THC in Q2 2013 and held it in 29 quarters. The position peaked at $5.32M in Q3 2015. 673 funds tracked by Wall St. Rank hold THC as of Q2 2026.
- GSA Capital Partners reported no remaining Tenet Healthcare position as of Q2 2026 after selling out during the quarter.
- GSA Capital Partners sold 1,800 Tenet Healthcare shares in Q2 2026, an estimated $340K.
- GSA Capital Partners first reported a position in Tenet Healthcare in Q2 2013 and held it in 29 quarters.
- GSA Capital Partners's Tenet Healthcare position peaked at $5.32M in Q3 2015.
- 673 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.
Based on GSA Capital Partners's 13F filing for Q2 2026, filed 6 Aug 2026.